scorecardresearch
Monday, August 11, 2025
TopicAstraZeneca

Topic: AstraZeneca

Argentina approves AstraZeneca-Oxford Covid vaccine for emergency use

The vaccine was given approval for emergency use over the course of the next year, accoarding to a statement by Argentina’s health regulator ANMAT.

UK approves AstraZeneca-Oxford Covid vaccine for emergency use

The vaccine will be prioritised for the country’s most vulnerable groups. It’s the second Covid vaccine to be cleared for emergency use in the UK after Pfizer and BioNTech.

UK poised to approve AstraZeneca Covid shot as need for vaccines grows

The go-ahead would come about three weeks after the UK became the first western country to begin vaccinations, using a shot from Pfizer and BioNTech.

UK says Oxford vaccine review ongoing, won’t be approved until safety, efficacy standards met

UK's Medicines and Healthcare products Regulatory Agency tells ThePrint vaccine review includes poring over pages of lab data. If cleared, it will likely boost chances of the vaccine's approval in India.

AstraZeneca plans post-Covid growth with $39 billion deal with Alexion Pharmaceuticals

The proposed cash-and-stock acquisition will add treatments for uncommon blood and immunological disorders to the portfolio of the Cambridge-based drugmaker.

AstraZeneca to test if combination of its Covid vaccine with Russia’s Sputnik V works better

Based on a monkey-adenovirus vector, AstraZeneca’s vaccine reported average effectiveness of 70%. Sputnik is the only Covid vaccine to use two different human-adenovirus vectors.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

How AstraZeneca can recover from its Covid vaccine stumble

Even without a new trial, AstraZeneca can regain confidence in its research and vaccine – which still seems to show great promise – by releasing more granular data.

Alleging serious side-effects, vaccine trial participant seeks Rs 5 cr from Serum Institute

Chennai-based participant also sends legal notice to ICMR, DCGI, AstraZeneca & Oxford University to stop testing, manufacturing & distributing vaccine.

UK asks regulator to approve Oxford-AstraZeneca vaccine for temporary supply

If authorised, the UK will be one of the first countries in the world to receive the vaccine. AstraZeneca expects to have up to 4 million doses ready by the end of 2020.

On Camera

MBBS guidelines for students with disabilities reduce a life to a limb

The guidelines ask whether a student can climb stairs, but not whether the college has a ramp. They ask whether a student can bear weight, but not whether the system can bear the weight of its own prejudice.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

Legacy of Air Chief Marshal LM Katre, the man who flew Spitfires & ushered IAF into a modern era

ACM Katre was 2nd IAF chief to die in harness. It was at a memorial lecture in his honour where IAF chief AP Singh revealed that India shot down 6 Pakistani aircraft in Op Sindoor.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.